Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results


2011 | 6 | 5 | 652-661

Article title

The relationships between depression and life activities and well-being of multiple sclerosis patients


Title variants

Languages of publication



Multiple sclerosis (MS) is one of the most disabling neurodegenerative disorders. Depression is the most frequent psychiatric disorder accompanying MS. Although much attention is given to correlations between depression and MS clinical factors, analysis of correlations between depression and life activities (social, household, professional activities and family life) and the well-being of MS patients’ is insufficient. However, improvement of these functions could positively influence the outcomes of MS treatment. The aim of this study was to evaluate relationships between depression, life activities of MS patients, and their proposals how to improve the well-being. Materials and methods. The study lasted three years with 270 adult MS patients involved in it. ICD-10 criteria were used to diagnose depression. Original questionnaire was used to measure life activities and the well-being of the patients. Results. Prevalence of depression was 20.7% with no difference regarding the gender. Almost 84% of depressed respondents indicated, that MS disturbs their family life, 71.4% recommended to assign more attention to MS in general and 64.3% - to include more medications into reimbursement list. Conclusions. MS patients diagnosed with depression significantly more often than non-depressed indicate that MS disturbs their family life; recommend to assign more attention to MS in general and to include more medications into reimbursement list.










Physical description


1 - 10 - 2011
9 - 8 - 2011


  • Department of Psychiatry of Medical Academy of Lithuanian University of Health Sciences, LT-50009, Kaunas, Republic of Lithuania
  • Department of Psychiatry of Medical Academy of Lithuanian University of Health Sciences, LT-50009, Kaunas, Republic of Lithuania
  • Department of Psychiatry of Medical Academy of Lithuanian University of Health Sciences, LT-50009, Kaunas, Republic of Lithuania


  • [1] Pugliatti M., Sotgiu S., Rosati G., The worldwide prevalence of multiple sclerosis, Clin. Neurol. Neurosurg., 2002, 104(3), 182–191 http://dx.doi.org/10.1016/S0303-8467(02)00036-7[Crossref]
  • [2] Pugliatti M., Rosati G., Carton H., Riise T., Drulovic J., Vecsei L., et al., The epidemiology of multiple sclerosis in Europe, Eur. J. Neurol., 2006, 13(7), 700–722 http://dx.doi.org/10.1111/j.1468-1331.2006.01342.x[Crossref]
  • [3] Frohman E.M., Racke M.K., Raine C.S., Multiple sclerosis - the plaque and its pathogenesis, N. Engl. J. Med., 2006, 354(9), 942–955 http://dx.doi.org/10.1056/NEJMra052130[Crossref]
  • [4] Bar-Or A., Immunology of multiple sclerosis, Neurol. Clin., 2005, 23, 149–175 http://dx.doi.org/10.1016/j.ncl.2004.11.001[Crossref]
  • [5] Janardhan V., Bakshi R., Quality of life in patients with multiple sclerosis: the impact of fatigue and depression, J. Neurol. Sci.., 2002, 205(1), 51–58 http://dx.doi.org/10.1016/S0022-510X(02)00312-X[Crossref]
  • [6] Giannini M.J., Bergmark B., Kreshover S., Elias E., Plummer C., O’Keefe E., Understanding suicide and disability through three major disabling conditions: Intellectual disability, spinal cord injury, and multiple sclerosis, Disabil. Health J., 2010, 3(2), 74–78 http://dx.doi.org/10.1016/j.dhjo.2009.09.001[Crossref]
  • [7] Fragoso Y.D., Frota E.R., Lopes J.S., Noal J.S., Giacomo M.C., Gomes S., et al., Severe depression, suicide attempts, and ideation during the use of interferon beta by patients with multiple sclerosis, Clin. Neuropharmacol., 2010, 33(6), 312–316 http://dx.doi.org/10.1097/WNF.0b013e3181f8d513[Crossref]
  • [8] Patten S.B., Beck C.A., Williams J.V., Barbui C., Metz L.M., Major depression in multiple sclerosis: a population-based perspective, Neurology, 2003, 61(11), 1524–1527 [Crossref]
  • [9] Siegert R.J., Abernethy D.A., Depression in multiple sclerosis: a review, J. Neurol. Neurosurg. Psychiatry, 2005, 76(4), 469–475 http://dx.doi.org/10.1136/jnnp.2004.054635[Crossref]
  • [10] Chwastiak L., Ehde D.M., Gibbons L.E., Sullivan M., Bowen J.D., Kraft G.H., Depressive symptoms and severity of illness in multiple sclerosis: epidemiological study of a large community sample, Am. J. Psychiatry, 2002, 159(11), 1862–1868 http://dx.doi.org/10.1176/appi.ajp.159.11.1862[Crossref]
  • [11] Wynia K., Middel B., van Dijk J.P., De Keyser J.H., Reijneveld S.A., The impact of disabilities on quality of life in people with multiple sclerosis, Mult. Scler., 2008, 14, 972–980 http://dx.doi.org/10.1177/1352458508091260[Crossref]
  • [12] Putzki N., Fischer J., Gottwald K., Reifschneider G., Ries S., Siever A., et al., Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis, Eur. J. Neurol., 2009, 16, 713–720 http://dx.doi.org/10.1111/j.1468-1331.2009.02572.x[Crossref]
  • [13] Hermann B.P., Vickrey B., Hays R.D., Cramer J., Devinsky O., Meador K., et al., A comparison of health-related quality of life in patients with epilepsy, diabetes, and multiple sclerosis, Epilepsy Res. 1996, 25(2), 113–118 http://dx.doi.org/10.1016/0920-1211(96)00024-1[Crossref]
  • [14] Hart S., Fonareva I., Merluzzi N., Mohr D.C., Treatment for depression and its relationship to improvement in quality of life and psychological well-being in multiple sclerosis patients, Quality of Life Res., 2005, 14(3), 695–703 http://dx.doi.org/10.1007/s11136-004-1364-z[Crossref]
  • [15] Sobocki P., Pugliatti M., Lauer K., Kobelt G., Estimation of the cost of MS in Europe: extrapolations from a multinational cost study, Mult. Scler., 2007, 13(8), 1054–1064 http://dx.doi.org/10.1177/1352458507077941[Crossref]
  • [16] Riazi A., Hobart J., Lamping D., Fitzpatrick R., Freeman J., Jenkinson C., at al., Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson’s disease with normal population health profiles, J. Neurol. Neurosurg. Psychiatry, 2003, June, 74(6), 710–714 http://dx.doi.org/10.1136/jnnp.74.6.710[Crossref]
  • [17] Kurtzke J.F., Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS), Neurology, 1983, 33(11), 1444–1452 [Crossref]
  • [18] Moran P.J., Mohr D.C., The validity of Beck Depression Inventory and Hamilton Rating Scale for Depression items in the assessment of depression among patients with multiple sclerosis, J. Behav. Med., 2005, 28(1), 35–41 http://dx.doi.org/10.1007/s10865-005-2561-0[Crossref]
  • [19] Zung W.W.K., A self-rating depression scale, Arch. Gen. Psychiatry, 1965, 12, 63–70 [Crossref]
  • [20] Friedman S., Even C., Samuelian J.C., Guelfi J.D., Factor structure of the Hospital Anxiety and Depression (HAD) Scale, B. J. Psychiatry, 2002, 181(8), 165–166
  • [21] The ICD-10 Classification of Mental and Behavioural Disorders, Diagnostic criteria for research, World Health Organization, Geneva, 1993
  • [22] Arnett P.A., Randolph J.J., Longitudinal course of depression symptoms in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 2006, 77(5), 606–610 http://dx.doi.org/10.1136/jnnp.2004.047712[Crossref]
  • [23] Galeazzi G.M., Ferrari S., Giaroli G., Mackinnon A., Merelli E., Motti L., et al., Psychiatric disorders and depression in multiple sclerosis outpatients: impact of disability and interferon beta therapy, Neurol. Sci., 2005, 26(4), 255–262 http://dx.doi.org/10.1007/s10072-005-0468-8[Crossref]
  • [24] McGuigan C., Hutchinson M., Unrecognized symptoms of depression in a community-based population with multiple sclerosis, J. Neurol., 2006, 253(2), 219–232 http://dx.doi.org/10.1007/s00415-005-0963-0[Crossref]
  • [25] Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., et al., The epidemiology of major depressive disorder. Results from the National Comorbidity Survey Replication (NCS-R), JAMA, 2003, 289(23), 3095–3105 http://dx.doi.org/10.1001/jama.289.23.3095[Crossref]
  • [26] Rihmer Z., Angst J., Mood disorders: epidemiology, In: Kaplan & Sadock’s Comprehensive Textbook of Psychiatry, 8th ed. (1), Lippincott Williams & Wilkins, Philadelphia, 2005, 1575–1582
  • [27] Piccinelli M., Wilkinson G., Gender differences in depression. Critical review, Br. J. Psychiatry, 2000, 177, 486–492 http://dx.doi.org/10.1192/bjp.177.6.486[Crossref]
  • [28] Buchanan R.J., Wang S., Tai-Seale M., Ju H., Analyses of nursing home residents with multiple sclerosis and depression using the Minimum Data Set, Mult. Scler., 2003, March, 9(2), 171–188 http://dx.doi.org/10.1191/1352458503ms872oa[Crossref]
  • [29] Chwastiak L.A., Ehde D.M., Psychiatric Issues in Multiple Sclerosis, Psychiatr. Clin. North. Am., 2007, 30(4), 803–817 http://dx.doi.org/10.1016/j.psc.2007.07.003[Crossref]
  • [30] Sollom A.C., Kneebone I.I., Treatment of depression in people who have multiple sclerosis. Mult. Scler., 2007, Jun, 13(5), 632–635 http://dx.doi.org/10.1177/1352458507072384[Crossref]
  • [31] Blazer D.G., Depression in late life: review and commentary, J. Geront.: Med. Sci., 2003, 58A(3), 249–265 http://dx.doi.org/10.1093/gerona/58.3.M249[Crossref]
  • [32] Tandberg E., Larsen J.P., Aarsland D., Cummings J.L, The occurrence of depression in Parkinson’s disease. A community-based study, Arch. Neurol., 1996, 53(2), 175–179 [Crossref]
  • [33] Reijnders J. S., Ehrt U., Weber W. E., Aarsland D. and Leentjens A. F., A systematic review of prevalence studies of depression in Parkinson’s disease. Mov. Disord., 2008, 23(2), 183–189 http://dx.doi.org/10.1002/mds.21803[Crossref]
  • [34] Massie M.J., Prevalence of depression in patients with cancer, J. Natl. Cancer Inst. Monogr., 2004, 32, 57–71 http://dx.doi.org/10.1093/jncimonographs/lgh014[Crossref]
  • [35] Ciaramella A., Poli P., Assessment of depression among cancer patients: the role of pain, cancer type and treatment, Psychooncology, 2001, 10(2), 156–165 http://dx.doi.org/10.1002/pon.505[Crossref]
  • [36] Anderson R.J., Freedland K.E., Clouse R.E., Lustman P.J., The prevalence of comorbid depression in adults with diabetes. A meta-analysis, Diabetes Care, 2001, 24(6), 1069–1078 http://dx.doi.org/10.2337/diacare.24.6.1069[Crossref]
  • [37] Goldney R.D., Phillips P.J., Fisher L.J., Wilson D.H., Diabetes, depression, and quality of life: a population study, Diabetes Care, 2004, 27(5), 1066–1070 http://dx.doi.org/10.2337/diacare.27.5.1066[Crossref]
  • [38] Thombs B.D., Bass E.B., Ford D.E., Stewart K.J., Tsilidis K.K., Patel U., et al., Prevalence of depression in survivors of acute myocardial infarction, J. Gen. Int. Med., 2006, 21, 30–38 http://dx.doi.org/10.1111/j.1525-1497.2005.00269.x[Crossref]
  • [39] Beal C., Stuifbergen A.K., Sands D.V., Brown A., Depression in multiple sclerosis: a longitudinal analysis, Arch. Psychiatr. Nurs., 2007, 21, 181–191 http://dx.doi.org/10.1016/j.apnu.2007.02.008[Crossref]
  • [40] Minden S.L., Mood disorders in multiple sclerosis: diagnosis and treatment, J. Neurovirol., 2000, 6(2), 160–167
  • [41] Pfleger C.C., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis (1): early pension and temporary unemployment-a historical prospective cohort study, Mult. Scler., 2010, Jan, 16(1), 121–126 http://dx.doi.org/10.1177/1352458509352196[Crossref]
  • [42] Pfleger C.C., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis: clinical and demographic predictors - a historical prospective cohort study, Eur. J. Neurol., 2010, 17(11), 1346–1351
  • [43] Julian L.J., Vella L., Vollmer T., Hadjimichael O., Mohr D.C., Employment in multiple sclerosis. Exiting and re-entering the work force, J. Neurol., 2008, 255(9), 1354–1360 http://dx.doi.org/10.1007/s00415-008-0910-y[Crossref]
  • [44] Busche K.D., Fisk J.D., Murray T.J., Metz L.M., Short term predictors of unemployment in multiple sclerosis patients. Can. J. Neurol. Sci., 2003, 30(2), 137–142
  • [45] Putzki M., Fischer J., Gottwald K., Reifschneider G., Ries S., Siever A. et al., Quality of life in 1000 patients with early relapsing-remitting multiple sclerosis, Eur. J. Neurol., 2009, 16(6), 713–720 http://dx.doi.org/10.1111/j.1468-1331.2009.02572.x[Crossref]
  • [46] Jongen P.J., Sindic C., Carton H., Zwanikken C., Lemmens W., Borm G., Improvement of health-related quality of life in relapsing remitting multiple sclerosis patients after 2 years of treatment with intramuscular interferon beta - 1a. J. Neurol., 2010, Apr, 257(4), 584–589 http://dx.doi.org/10.1007/s00415-009-5378-x
  • [47] Einarsson U., Gottberg K., Fredrikson S., von Koch L., Holmqvist L.W., Activities of daily living and social activities in people with multiple sclerosis in Stockholm County, Clin. Rehabil., 2006, 20(6), 543–551 http://dx.doi.org/10.1191/0269215506cr953oa[Crossref]
  • [48] Buhse M., Assessment of caregiver burden in families of persons with multiple sclerosis, J. Neurosci. Nurs., 2008, 40(1), 25–31 http://dx.doi.org/10.1097/01376517-200802000-00005[Crossref]
  • [49] Pfleger C.C., Flachs E.M., Koch-Henriksen N., Social consequences of multiple sclerosis. Part 2. Divorce and separation: a historical prospective cohort study, Mult. Scler., 2010, 16(7), 878–882 http://dx.doi.org/10.1177/1352458510370978
  • [50] MacLurg K., Reilly P., Hawkins S., Grav O., Evason E., Whittington D., A primary care-based needs assessment of people with multiple sclerosis, Br. J. Gen. Pract., 2005, 55(514), 378–383
  • [51] Vazirinejad R., Lilley J., Ward C., A health profile of adults with multiple sclerosis living in the community, Mult. Scler., 2008, 14(8), 1099–1105 http://dx.doi.org/10.1177/1352458508092264[Crossref]
  • [52] Koopman W.J., Benbow C.L., Vandervoort M., Top 10 needs of people with multiple sclerosis and their significant others. J. Neurosci. Nurs., 2006, 38(5), 369–373 http://dx.doi.org/10.1097/01376517-200610000-00008[Crossref]

Document Type

Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.